What's in Chengdu Qingshan Likang Pharmaceutical Co., Ltd's pipeline?

Chengdu Qingshan Likang Pharmaceutical Co., Ltd has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Chengdu Qingshan Likang Pharmaceutical Co., Ltd's portfolio?

Top competitors by shared drug class: Chinese PLA General Hospital, Chinese University of Hong Kong, University of Erlangen-Nürnberg Medical School, Vantive Health LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/chengdu-qingshan-likang-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Chengdu Qingshan Likang Pharmaceutical Co., Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chengdu Qingshan Likang Pharmaceutical Co., Ltd pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
glucose peritoneal dialysis solution	glucose peritoneal dialysis solution	marketed	Peritoneal dialysis solution		Nephrology

Therapeutic area mix

Nephrology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Chinese PLA General Hospital · 1 shared drug class
Chinese University of Hong Kong · 1 shared drug class
University of Erlangen-Nürnberg Medical School · 1 shared drug class
Vantive Health LLC · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Chengdu Qingshan Likang Pharmaceutical Co., Ltd:

Cite this brief

Drug Landscape (2026). Chengdu Qingshan Likang Pharmaceutical Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/chengdu-qingshan-likang-pharmaceutical-co-ltd. Accessed 2026-05-17.